Dow Up0.11% Nasdaq Up0.50%

More On 8158.HK

Quotes

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials


China Bio-Med Regeneration Technology Limited (8158.HK)

-HKSE
0.29 0.00(0.00%) 3:59AM EDT
ProfileGet Profile for:
China Bio-Med Regeneration Technology Limited
Dah Sing Financial Centre
31st Floor
Wanchai,
Hong Kong - Map
Phone: 852 3966 8388
Fax: 852 2802 0026
Website: http://www.bmregeneration.com

Details 
Index Membership:N/A
Sector:Healthcare
Industry:Biotechnology
Full Time Employees:352

Business Summary 

China Bio-Med Regeneration Technology Limited, an investment holding company, is engaged in the research, development, production, and sale of tissue engineering skin related products. The company’s tissue engineering skin products include ActivSkin, which is used to cure injuries due to accidents and diseases occurring from infection, ulcer, burn, complication of surgeries, and congenital abnormalities; and Acellular Cornea for the treatment of various kinds of cornea diseases, including cornea lamellar defect, cornea alkali burn, and bacteria corneal ulcer. Its other development products comprise Selective Acellular Porcine Skin for the treatment of various skin injuries, infected, and deficient wounds, as well as enhance healing of scars and chronic non-healing ulcers and prevent recurrence; and Boactive cosmetics. The company was formerly known as B M Intelligence International Limited and changed its name to China Bio-Med Regeneration Technology Limited in December 2008. China Bio-Med Regeneration Technology Limited was founded in 1995 and is headquartered in Wanchai, Hong Kong.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on China Bio-Med Regeneration Technology Limited

Key Executives 
 PayExercised
Mr. Zhengkang Shao ,
Chief Exec. Officer
1.26MN/A
Mr. Yumin Dai , 53
Compliance Officer and Exec. Director
1.46MN/A
Mr. Long Ma , 55
Chief Internal Auditor and Non-Exec. Director
1.20MN/A
Ms. Yurong Wang , 52
Exec. Director
1.42MN/A
Ms. Chan Yim ,
Company Sec.
N/AN/A
Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in HKD.